MDS clinical diagnostic criteria for Parkinson's diseaseRonald B. Postuma, Günther Deuschl, Daniela Berg et al.|Movement Disorders|2015Cited by 7.4k
MDS research criteria for prodromal Parkinson's diseaseDaniela Berg, Günther Deuschl, Ronald B. Postuma et al.|Movement Disorders|2015Cited by 1.3k
Validation of the MDS clinical diagnostic criteria for Parkinson's diseaseRonald B. Postuma, Daniela Berg, Werner Poewe et al.|Movement Disorders|2018Cited by 299
A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementiaShifu Xiao, Raoli He, Zhongxin Zhao et al.|Alzheimer s Research & Therapy|2021Cited by 200
Movement disorder society criteria for clinically established early Parkinson's diseaseDaniela Berg, Ronald B. Postuma, Charles H. Adler et al.|Movement Disorders|2018Cited by 172